Ftse Mib
37.097,04
-0,07%
DAX
21.906,21
-0,03%
S&P 500
6.093,12
0,16%
NASDAQ
19.791,99
0,00%
Bitcoin
99.649,99
3,18%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Catalyst Pharmaceuticals Inc (CPRX) Catalyst Pharmaceuticals Inc (CPRX) Notizie

Catalyst Pharmaceuticals Inc

CPRX
23,16
0,10 (0,43%)
Pre Mercato
Ultimo aggiornamento: 15:23:55
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/1/202522:30EDGAR2Form 8-K - Current report
23/1/202514:03GLOBECatalyst Pharmaceuticals Receives Prestigious Ranking on..
21/1/202522:30EDGAR2Form 8-K - Current report
21/1/202514:19GLOBECatalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma..
08/1/202522:43EDGAR2Form 8-K - Current report
08/1/202518:30GLOBECatalyst Pharmaceuticals Announces Settlement of FIRDAPSE®..
31/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202414:03GLOBECatalyst Pharmaceuticals to Present at the 43rd Annual J.P...
11/12/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202418:55EDGAR2Form 144 - Report of proposed sale of securities
30/11/202402:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202402:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202415:42EDGAR2Form 144 - Report of proposed sale of securities
26/11/202418:37EDGAR2Form 144 - Report of proposed sale of securities
25/11/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202414:03GLOBECatalyst Pharmaceuticals Recognized as One of North..
19/11/202414:03GLOBECatalyst Pharmaceuticals to Participate in Upcoming Investor..
13/11/202414:03GLOBECatalyst Pharmaceuticals Recognized Among BioSpace 2025 Best..
06/11/202423:10EDGAR2Form 8-K - Current report
06/11/202422:12GLOBECatalyst Pharmaceuticals Reports Strong Third Quarter 2024..
06/11/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
22/10/202414:03GLOBECatalyst Pharmaceuticals to Report Third Quarter 2024..
18/10/202421:31EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
08/10/202414:03GLOBECatalyst Pharmaceuticals Donates $100,000 to the American..
26/9/202414:42EDGAR2Form 8-K - Current report
24/9/202412:00GLOBECatalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma..
22/8/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202422:42EDGAR2Form 144 - Report of proposed sale of securities
20/8/202414:03GLOBECatalyst Pharmaceuticals to Participate in Upcoming Investor..
13/8/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202417:24EDGAR2Form 144 - Report of proposed sale of securities
07/8/202422:32EDGAR2Form 8-K - Current report
07/8/202422:11GLOBECatalyst Pharmaceuticals Reports Strong Second Quarter 2024..
26/7/202422:30EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 23,06

La tua Cronologia

NASDAQ
CPRX
Catalyst Pharmaceuticals
BIT
UC1MGU
Unicredit Bank
BIT
UB5FVM
Unicredit Bank
BIT
UC467E
Unicredit Bank
BIT
S25038
SG ISSUER
BIT
UC1TAS
Unicredit Bank
BIT
3STS
Graniteshares 3x Short T...
AQSE
HOGS.GB
WisdomTree Commodity Sec...
AQSE
FIND.GB
WisdomTree Commodity Sec...
BIT
P130H5
BNP PARIBAS ISSUANCE
BIT
F28266
Vontobel Financial Produ...
BIT
P22841
Bnp Paribas Issuance
BIT
P14XV2
BNP Paribas Issuance
BIT
DIG22
Digital360
BIT
1LEVI
Levi Strauss &
BIT
DSUS
Etf
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci